ARTICLE | Company News
Migragen, Morphochem neurological deal
July 3, 2002 7:00 AM UTC
The companies partnered to identify, optimize and develop small molecules for nerve regeneration in patients with spinal cord injury and traumatic brain injury. The deal combines Morphochem's multi-co...